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Introduction
Mitochondrial fusion plays an important role in controlling the 
shape and function of mitochondria (Okamoto and Shaw, 2005; 
Chan, 2006). In mammalian cells, the dynamin-related GTPase 
OPA1 is essential for mitochondrial fusion (Cipolat et al., 2004; 
Chen et al., 2005). The yeast OPA1 orthologue Mgm1 is also 
  essential for fusion (Wong et al., 2000, 2003; Sesaki et al., 2003b) 
and has been shown to form oligomers important for tethering 
and fusion of the inner membranes (Meeusen et al., 2006). OPA1 
is associated with the inner membrane and protects cells from 
apoptosis by regulating inner membrane dynamics (Olichon et al., 
2003; Frezza et al., 2006). Mutation of OPA1 causes the disease 
dominant optic atrophy, a degeneration of the retinal ganglion 
cells (Alexander et al., 2000; Delettre et al., 2000).
Both OPA1 and Mgm1 undergo proteolytic processing, 
and, in the case of Mgm1, such processing has been shown to be 
essential for mitochondrial fusion activity (Herlan et al., 2003; 
McQuibban et al., 2003; Sesaki et al., 2003a; Ishihara et al., 
2006). Yeast Mgm1 is produced as a precursor with a mito-
chondrial leader sequence that is cleaved by the mitochondrial 
processing peptidase (MPP). Mgm1 processed by only MPP 
leads to the long isoform, l-Mgm1. The mitochondrial rhomboid 
Pcp1/Rbd1 further cleaves a subset of Mgm1 to form the short 
isoform, s-Mgm1 (Herlan et al., 2003; McQuibban et al., 2003; 
Sesaki et al., 2003a). Loss of Pcp1 greatly reduces mitochondrial 
fusion because a mixture of both the long and short Mgm1 
isoforms is essential for normal activity (Herlan et al., 2003).
Several issues concerning OPA1 processing remain enig-
matic. In contrast to the two isoforms produced by Mgm1, OPA1 
produces many more isoforms. OPA1 is encoded by a compli-
cated set of at least eight mRNA splice forms that are produced 
by differential splicing (Delettre et al., 2001). In addition to the 
MPP processing site, the polypeptides encoded by each mRNA 
splice form contain an S1 cleavage site, and some also contain a 
more C-terminal S2 cleavage site (Fig. 1 A; Ishihara et al., 2006). 
In principle, therefore, each mRNA splice form can produce a 
long isoform (produced by cleavage with MPP alone) and one 
or more short isoforms (produced by cleavage at S1 or S2). 
The proteases acting at sites S1 and S2 are poorly understood. 
There is evidence for the involvement of both the rhomboid 
protease presenilin-associated rhomboid-like (PARL) and the 
m-AAA protease paraplegin in OPA1 processing (Cipolat et al., 
2006; Ishihara et al., 2006). However, cells lacking PARL or 
paraplegin have normal OPA1 processing (Duvezin-Caubet et al., 
2007), suggesting that other proteases remain to be identifi  ed. 
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In addition, when reconstituted in yeast cells, OPA1 cleavage 
appears to depend on two other m-AAA proteases, Afg3L1 and 
Afg3L2 (Duvezin-Caubet et al., 2007). In contrast to Mgm1, it 
has been suggested that the long form of OPA1 isoform 1 is the 
fusion-active species (Ishihara et al., 2006). As a result, it is un-
clear whether proteolytic processing is simply a way to inactive 
OPA1 or whether the short isoforms have another function. To 
clarify these issues, we developed a cellular system to study the 
role of specifi  c OPA1 isoforms in mitochondrial fusion. We fi  nd 
that a combination of long and short OPA1 isoforms is important 
for mitochondrial fusion activity. Moreover, we fi  nd that the 
i-AAA protease Yme1L regulates OPA1 processing.
Results and discussion
Mitochondrial fusion activity of distinct 
OPA1 mRNA splice forms
As a result of eight mRNA splice forms (Delettre et al., 2001) and 
subsequent proteolytic processing, OPA1 isoforms migrate as a 
complex mixture of at least fi  ve bands (a–e) on gel electrophoresis 
(Fig. 1, A and B). The bands a and b are thought to be a mixture 
of long isoforms of OPA1, whereas the shorter bands (c–e) are 
thought to result from additional proteolytic processing (Ishihara 
et al., 2006). The complexity of this mixture prevents the defi  ni-
tive assignment of function to specifi  c mRNA splice forms and 
Figure 1.  OPA1 mRNA splice forms that are partially processed have substantial mitochondrial fusion activity in isolation. (A) Schematic of the eight OPA1 
mRNA splice forms. The mRNA splice forms differ in the presence or absence of exons 4, 4b, and 5b. Cleavage of the mitochondrial targeting sequence 
(MTS) by MPP leads to the long isoforms. Additional cleavage at sites S1 (exon 5) or S2 (exon 5b) leads to the short isoforms. TM, transmembrane. (B) Pro-
cessing of polypeptides encoded by individual OPA1 mRNA splice forms. The eight OPA1 mRNA splice forms were expressed in OPA1-null MEFs, which 
contain no OPA1 protein. OPA1 was detected by Western blot analysis with an anti-OPA1 antibody. The ﬁ  ve bands detected in wild-type cells are indi-
cated. Actin was used as a loading control. (C) Tubulation of mitochondria in OPA1-null cells by individual OPA1 mRNA splice forms. The eight OPA1 
mRNA splice forms were expressed in OPA1-null cells containing mitochondrially targeted DsRed, and mitochondrial morphology was scored according to 
the criteria detailed in Materials and methods. 100 cells were scored in each experiment; error bars indicate SD in three independent experiments. 
(D) Mitochondrial fusion activity of individual OPA1 mRNA splice forms. The eight OPA1 splice forms were expressed in OPA1-null cells, and mitochondrial 
fusion was scored in the PEG cell hybrid assay at 7 h after cell fusion.CONTROL OF OPA1 FUNCTION BY PROTEOLYTIC PROCESSING • SONG ET AL. 751
their processed polypeptides. To circumvent these complications, 
we analyzed the mitochondrial fusion activity of the eight known 
human OPA1 mRNA splice forms upon expression in OPA1-
null mouse embryonic fi  broblasts (MEFs; Fig. 1). The parental 
OPA1-null cells contain no OPA1 protein and have completely 
fragmented mitochondria as a result of the lack of mitochondria 
fusion (unpublished data; Fig. 1, B and C). Of the eight OPA1 
mRNA splice forms, the expression of isoforms 1, 2, 4, and 7 
result in the robust tubulation of mitochondria in OPA1-null cells 
(Fig. 1 C). In contrast, splice forms 3, 5, 6, and 8 have modest or 
barely detectable tubulation activity. The ability of OPA1 splice 
forms to tubulate mitochondria in OPA1-null cells correlates well 
with their mitochondrial fusion activity in a polyethylene glycol 
(PEG)–induced cell hybrid assay (Fig. 1 D and Fig. S1, available 
at http://www.jcb.org/cgi/content/full/jcb.200704110/DC1).
Interestingly, all of the mRNA splice forms with high levels 
of fusion activity produce a long form of OPA1 in addition to 
one or more further processed short forms (Fig. 1 B). All OPA1 
mRNA splice forms encode a protease processing site in exon 5 
(S1 site), and some contain a second site (S2) in the alternative 
exon 5b (Ishihara et al., 2006). mRNA splice forms 1 and 2 en-
code only site S1 and yield a single long and a single short form. 
mRNA splice forms 4 and 7 encode sites S1 and S2 and therefore 
yield two short forms in addition to a single long form. These 
  results illustrate the complexity of analyzing endogenous OPA1 
bands from wild-type cells. The top two bands (a and b) are gen-
erally thought to be the two long forms of OPA1, but our analysis 
indicates that there are at least four species of long forms.
In contrast, all of the mRNA isoforms with little fusion 
activity are processed with greater effi  ciency to yield only short 
forms of OPA1 (Fig. 1 B). These results suggest that the short 
isoforms produced by cleavage at S1 or S2 have little activity on 
their own. Interestingly, all of the mRNA splice forms producing 
highly processed polypeptides (3, 5, 6, and 8) contain exon 4b 
(Fig. 1 A). Polypeptides produced from mRNA splice forms 1 
and 2 are partially processed, whereas those from splice forms 5 
and 3, which are identical, respectively, except for the 4b inser-
tion, are fully processed. Similarly, polypeptides from splice 
forms 6 and 8 are identical to those from splice forms 4 and 7, 
respectively, except for the 4b insertion. These results indicate 
that peptide sequences encoded by exon 4b stimulate proteolytic 
processing. In future experiments, it will be interesting to deter-
mine whether exon 4b–containing transcripts are preferentially 
expressed under specifi  c cellular conditions. In yeast, produc-
tion of the short isoform of Mgm1 requires adequate ATP levels 
in the mitochondrial matrix, suggesting that Mgm1 processing is 
regulated by cellular metabolism (Herlan et al., 2004).
It should be noted that in our expression system, the total 
amount of exogenously expressed OPA1 is comparable with the 
total endogenous OPA1 in wild-type MEFs (Fig. 1 B). In contrast, 
gross overexpression of exogenous OPA1 is unable to rescue mito-
chondrial fusion activity in OPA1-null cells (unpublished data).
Long forms of OPA1 isoforms 1 and 2 
in isolation have little or no fusion activity
Previous experiments suggested that the long form of isoform 1 is 
the fusion-active species (Ishihara et al., 2006). This conclusion 
was based on analysis of an isoform 1 construct in which the S1 
cleavage site was removed by the deletion of 10 residues sur-
rounding alanine 195 (∆S1 mutation). To reexamine this issue, 
we analyzed the function of polypeptides containing the ∆S1 
mutation. As expected, OPA1 1∆S1 and 2∆S1 produce only the 
long form (Fig. 2 A). Splice forms 1 and 2 are the only ones 
lacking both the S2 cleavage site and exon 4b, thereby simplifying 
the analysis of processing. Whereas wild-type splice forms 1 
and 2 are able to induce tubulation in >50% of OPA1-null cells, 
the same splice forms lacking the S1 site, especially OPA1-1∆S1, 
have barely detectable activity (Fig. 2 B). Because the long 
forms of isoforms 1 and 2 are ineffective for mitochondrial fusion, 
these results indicate that proteolytic processing is important 
for OPA1 function.
Long and short forms of OPA1 
complement each other to reconstitute 
mitochondrial fusion activity
The aforementioned experiments indicate that neither the long 
forms nor the short forms in isolation are suffi  cient for mito-
chondrial fusion. Therefore, we tested whether a combination of 
long and short forms might be necessary. We analyzed whether 
1∆S1, which produces only a single long form with essentially 
no fusion activity (Fig. 2, A and B), could be complemented 
Figure 2.  The long forms of isoform 1 or isoform 2 lack substantial mito-
chondrial fusion activity. (A) Processing of mRNA splice forms 1 and 2 and 
their ∆S1 mutants. After expression in OPA1-null cells, Western blot analy-
sis was used to detect OPA1. Actin was used as a loading control. (B) Tubul-
ation of mitochondria in OPA1-null cells. After expression of the indi  cated 
splice forms in OPA1-null cells containing mitochondrially targeted DsRed, 
cells were scored as in Fig. 1 C; error bars indicate the SD from tripli-
cate experiments.JCB • VOLUME 178 • NUMBER 5 • 2007  752
by the additional expression of splice forms 3, 5, 6, or 8, which 
produce fully processed isoforms that also have little fusion activity 
(Fig. 1, B–D). As expected, coexpression produces a mixture of 
long and short forms (Fig. 3 A). All four combinations of co-
expression resulted in a synergistic increase in mitochondrial tu-
bulation in OPA1-null cells (Fig. 3 B). These results demonstrate 
that 1∆S1 and short forms work together to promote fusion.
To test this idea further, we analyzed ∆S1 versions of splice 
forms 3, 5, 6, and 8. Because of the 4b exon, the polypeptides 
produced from these splice forms are normally fully processed 
to yield only short forms that have little fusion activity. We 
hoped that by inhibiting cleavage at site S1, we could produce a 
mixture of long and short forms. In each case, the ∆S1 versions 
yield only a modest amount of the long form because OPA1 is 
still mostly processed (Fig. 3 C). In the case of 3∆S1 and 5∆S1, 
processing is caused by increased cleavage at sites other than S1. 
In the case of 6∆S1 and 8∆S1, cleavage still occurs effi  ciently 
at S2 based on the size of the processed bands. Remarkably, in 
each case, the ∆S1 mutants contain more mitochondrial fusion 
activity than the wild-type proteins (Fig. 3 D). These effects were 
most dramatic for 3∆S1 and 5∆S1. These results again indicate 
that a combination of long and short OPA1 isoforms is needed 
for effi  cient fusion activity.
Our results differ from a previous experiment showing that 
the expression of rat splice form 1∆S1 alone can tubulate mito-
chondria in cells treated with siRNA against OPA1 (Ishihara 
et al., 2006). We cannot rule out that rat and human OPA1 isoforms 
behave differently. However, because knockdown experiments 
do not completely deplete protein, it is likely that some short 
forms of OPA1 are retained in the siRNA-treated cells, thereby 
accounting for the apparent activity of the long isoform.
Isoform-speciﬁ  c control of OPA1 
processing and stability 
by membrane potential
Disruption of mitochondrial membrane potential by carbonyl 
 cyanide  m-chlorophenyl hydrazone (CCCP) has been shown to 
enhance the processing of OPA1, leading to accumulation of 
the short isoforms (Duvezin-Caubet et al., 2006; Ishihara et al., 
2006). Consistent with this idea, we found that CCCP treatment 
of OPA1-null cells expressing splice form 1 or 2 leads to accu-
mulation of the S1-cleaved short isoform (Fig. 4 A). However, 
this effect appears to involve not only increased processing at S1 
but also induced degradation of the long isoform. Upon treatment 
with CCCP, cells expressing 1∆S1 show a complete loss of the 
long isoform (Fig. 4 B). Under these conditions, a minor fraction 
of OPA1 is cleaved at a site other than S1, and this minor species 
is the only OPA1 that remains. With 2∆S1, most of the long 
isoform is also degraded. It should be noted that we observed this 
degradation only with a 4-h CCCP treatment, which is longer 
than in previous studies  (Duvezin-Caubet et al., 2006; Ishihara 
et al., 2006). Because CCCP treatment leads to the accumulation 
of short isoforms, we tested directly whether short isoforms are sta-
ble in the presence of CCCP. Expression of the exon 4b–containing 
splice forms (3, 5, 6, and 8) leads to fully processed isoforms that 
are stable after CCCP treatment (Fig. 4 C).
Given the enhanced cleavage at site S1 in the presence of 
CCCP, we also examined its effect on cleavage at S2. Variants 
4∆S1 and 7∆S1 produce only a single short isoform as a result of 
cleavage at site S2 (Fig. 4 D). Upon CCCP treatment, the long 
isoform disappears, but without an increased accumulation of 
the S2-cleaved isoform. In addition, there is a small accumulation 
of a novel cleavage product. Collectively, these results indicate 
that the loss of membrane potential enhances OPA1 processing at 
Figure 3.  A combination of long and short OPA1 isoforms increases 
mitochondrial fusion. (A) Coexpression of 1∆S1 with short isoforms. The 
indicated constructs were expressed in OPA1-null cells and analyzed by 
Western blotting. (B) Functional complementation of 1∆S1. OPA1-null cells 
were infected with retrovirus expressing splice forms 3, 5, 6, or 8. Each in-
fected line along with an uninfected control was transfected with a control 
GFP vector or the GFP vector and OPA1-1∆S1. (C) Processing of ∆S1 
mutants. The indicated splice forms and mutants were expressed in OPA1-
null cells. OPA1 was detected by Western blot analysis. Asterisks indicate 
novel cleavage products for 3∆S1 and 5∆S1. (D) Enhanced tubulation 
of mitochondria by ∆S1 mutants. The indicated OPA1 splice forms and 
mutants were expressed in OPA1-null cells. (B and D) Mitochondrial 
morphology was scored as in Fig. 1 C; error bars indicate the SD from 
triplicate experiments.CONTROL OF OPA1 FUNCTION BY PROTEOLYTIC PROCESSING • SONG ET AL. 753
S1 but not S2, suggesting that these sites are under differential 
regulation. In addition, the loss of membrane potential leads to 
degradation of the long isoforms but not the short ones.
The intermembrane space protease Yme1L 
regulates OPA1 cleavage at site S2 
but not S1
The different response of S1 versus S2 cleavage to the loss of 
membrane potential suggests that the two sites may be regulated 
by different proteases. Previous studies have implicated both 
m-AAA proteases and the rhomboid protease PARL in OPA1 
processing (Cipolat et al., 2006; Ishihara et al., 2006; Duvezin-
Caubet et al., 2007). However, the depletion of these proteases 
had only limited effects on OPA1 processing (Duvezin-Caubet 
et al., 2007), indicating that additional proteases might be in-
volved. Yme1L is an i-AAA protease anchored in the inner 
membrane with its protease domain located within the inter-
membrane space (Shah et al., 2000; Arnold and Langer, 2002). 
Short hairpin RNA (shRNA) against Yme1L effectively reduces 
protein levels (Fig. 5 A), and we examined its effect on OPA1 
processing. Knockdown of Yme1L has no effect on isoform 1 
processing, which occurs exclusively at site S1 (Fig. 5 B). In 
contrast, for isoforms 4 and 7, which contain both sites S1 and S2, 
Yme1L shRNA reduces the level of the S2-cleaved product and 
increases the level of the S1-cleaved product. By densitometry 
of the Western blots, the ratio of the S1-cleaved band to the 
S2-cleaved band was 0.4 and 0.6 for isoforms 4 and 7, respectively, 
without treatment. With the Yme1L knockdown, this ratio rose 
to >3. Likewise, 7∆S1, which produces only the S2-cleaved 
product, shows reduced processing after shRNA treatment. In 
this case, the ratio of the long isoform to the S2-cleaved isoform 
rose from 1 to 3. Similar effects on the S1 and S2 cleavage prod-
ucts were observed with the exon 4b–containing splice forms 
6 and 8 (Fig. 5 C). These results indicate that Yme1L is impor-
tant for proteolytic processing at site S2. Isoform 5 has no S2 
cleavage site, but shRNA resulted in the slight accumulation of 
a long isoform. It may be that Yme1L is also involved in cleav-
age at sites other than S2.
As with paraplegin and PARL, it is not clear whether 
Yme1L directly cleaves OPA1 or affects another protease. Thus 
far, we have not been able to demonstrate a direct physical 
interaction between Yme1L and OPA1 by coimmunoprecipitation. 
Cleavage of site S2 by YmeL1 is topologically sensible be-
cause the S2 region would be expected to reside in the inter-
membrane space, where the protease domain of Yme1L is   located. 
In contrast, the protease activity of PARL resides within the in-
ner membrane, and the protease activities of m-AAA proteases 
reside within the matrix. If Yme1L does directly cleave OPA1, 
it would be the fi  rst example of a protein-processing function 
through site-specifi  c cleavage for Yme1L. Previously, the role 
of Yme1L was thought to be in degrading misfolded mito-
chondrial proteins in the intermembrane space (Arnold and 
Langer, 2002). Analogously, the m-AAA proteases have a role 
in protein quality control through protein degradation but have 
recently been found to also process proteins at specifi  c sites 
(Nolden et al., 2005; Ishihara et al., 2006; Duvezin-Caubet 
et al., 2007).
Our results provide insight into the function of distinct 
OPA1 isoforms. Importantly, they indicate that OPA1, like Mgm1, 
requires both long and short isoforms for effi  cient mitochondrial 
fusion activity. With this unifying property, it is likely that OPA1 
and Mgm1 have similar mechanisms of action. It is interesting 
to note that any combination of long and short OPA1 isoforms is 
able to reconstitute fusion activity. This observation suggests that 
the exact cleavage sites (S1 versus S2) may not be important in 
terms of protein function. Instead, the presence of multiple sites 
may enable increased fl  exibility in regulating OPA1 processing 
because the two sites appear to be cleaved by distinct proteases 
and respond differently to changes in membrane potential.
Finally, at least three types of mitochondrial proteases—
m-AAA proteases, the rhomboid PARL, and now the i-AAA pro-
tease Yme1L—appear to regulate OPA1 processing. By regulating 
Figure 4.  CCCP affects OPA1 processing 
and stability. (A) Effect of CCCP on isoforms 
1 and 2. The splice forms 1 and 2 were ex-
pressed in OPA1-null cells and treated with 
CCCP as indicated. OPA1 was detected by 
Western blotting. Actin was used as a load-
ing control. (B) Degradation of long forms 
of isoforms 1 and 2. Splice forms 1∆S1 and 
2∆S1 were expressed in OPA1-null cells and 
treated with CCCP as indicated. The asterisk 
indicates a new cleavage product with CCCP 
treatment of 1∆S1. (C) Resistance of short 
isoforms to degradation. OPA1 constructs were 
expressed in OPA1-null cells and treated 
with CCCP as indicated. (D) CCCP effect on 
site S1 versus S2. OPA1 splice forms and their 
mutants were expressed in OPA1-null cells and 
analyzed as in A. The S1- and S2-cleaved 
products for isoforms 4 and 7 are labeled. 
The arrow indicates a novel cleavage product 
with CCCP treatment.JCB • VOLUME 178 • NUMBER 5 • 2007  754
OPA1 isoforms through mRNA splicing, degradation of long 
isoforms, and multiple modes of proteolytic processing, mam-
malian cells may be able to rapidly control mitochondrial fusion 
in response to environmental stimuli.
Materials and methods
Cell culture, transfection, and PEG fusion assay
MEFs were maintained in DME containing 10% heat-inactivated FBS, 1 mM 
L-glutamine, and penicillin/streptomycin. For transfection of cells with ex-
pression constructs, LipofectAMINE 2000 (Invitrogen) was used according 
to the manufacturer’s speciﬁ  cations. In the experiments in Fig. 4, CCCP was 
used at 20 μM, and cells were analyzed at 4 h.
To test the fusion activity of OPA1 mRNA splice forms, OPA1-
null cells stably expressing mitochondrially targeted GFP or DsRed were 
infected with retrovirus encoding each OPA1 mRNA splice form. Pair-
wise PEG fusion assays were performed as described previously (Chen 
et al., 2003).
Plasmid construction and retroviral transduction
The eight isoforms of human OPA1 cDNA were ampliﬁ  ed by PCR from 
ﬁ   rst-strand cDNA and subcloned into the retroviral vector pMSCV-puro. 
Retrovirus production and infection were performed as described previ-
ously (Chen et al., 2003). Western blots of cell lysates were probed with an 
afﬁ  nity-puriﬁ  ed anti-OPA1 antibody raised against the C-terminal region of 
human OPA1 (gift of L. Griparic and A. van der Bliek, University of California, 
Los Angeles, Los Angeles, CA; Griparic et al., 2004).
shRNA construction
shRNAi against Yme1L was performed using a modiﬁ  ed retroviral vector 
with the H1 promoter to drive the expression of shRNAs (Chen et al., 2005). 
Three shRNAi constructs were tested, with the best results obtained with the 
vector constructed with the oligonucleotides 5′-G  A  T  C  C  C  C  G  T  G  G  C  A  G  A  G  G-
A  A  T  T  C  A  T  A  T  T  T  C  A  A  G  A  G  A  A  T  A  T  G  A  G  T  T  C  C  T  C  T  G  C  C  A  C  T  T  T  T  T  G  G  A  A  A  -3′ and 
5′-A  G  C  T  T  T  T  C  C  A  A  A  A  A  G  T  G  G  C  A  G  A  G  G  A  A  C  T  C  A  T  A  T  T  C  T  C  T  T  G  A  A  A  T  A  T  G-
A  A  T  T  C  C  T  C  T  G  C  C  A  C  G  G  G  -3′.
The annealed oligonucleotides were cloned into the retroviral vector 
linearized with BglII–HindIII. The targeted sequence of Yme1L was G  A  G  T-
G  G  C  A  G  A  G  G  A  A  C  T  C  A  T  A  T  . Western blot analysis was performed with a 
polyclonal antibody against Yme1L (gift of C. Koehler, University of California, 
Los Angeles, Los Angeles, CA).
Fluorescence microscopy
MEFs were grown on poly-L-lysine–treated coverslips and ﬁ  xed in 10% 
  formalin. Coverslips were mounted with GelMount (Biomeda). Images 
were acquired at room temperature with a camera (ORCA-ER; Hamamatsu) 
attached to a microscope (Axiovert 200M; Carl Zeiss MicroImaging, Inc.) 
controlled by Axiovision version 4.5 software (Carl Zeiss MicroImaging, 
Inc.). A 100× plan Apochromat NA 1.4 objective was used. Mitochondria 
were identiﬁ  ed by mitochondrially targeted GFP or DsRed.
To determine mitochondrial fusion activity, cells were visually scored 
under a ﬂ  uorescent microscope (Axiovert 200M; Carl Zeiss MicroImaging, 
Inc.) into four morphological classiﬁ  cations. Tubular refers to cells with only 
tubular mitochondria. >50% tubular refers to cells in which greater than half 
of the mitochondrial mass existed as tubules as opposed to spherical frag-
ments. <50% tubular refers to cells in which less than half of the mitochondrial 
mass existed as tubules. In addition, all cells in this class contained at 
Figure 5.  Yme1L knockdown reduces cleavage at site S2. 
(A) Knockdown of Yme1L. Lysates from control cells and cells 
expressing shRNA against Yme1L were analyzed by Western 
blotting against Yme1L. Actin was used as a loading control. 
(B) Effect of Yme1L knockdown on the proteolytic processing 
of isoforms 1, 4, and 7. OPA1 splice forms and mutants were 
expressed in OPA1-null cells and treated with shRNA against 
Yme1L as indicated. OPA1 was detected by Western blotting. 
For isoforms 4 and 7, the S2-cleaved short isoform is the low-
est band, as indicated. These results are quantitated by densi-
tometry in the bottom panel. For splice form 1 and 7∆S1, the 
ratio of the long isoform to the short isoform is presented. For 
splice forms 4 and 7, which produce S1- and S2-cleaved 
products, the ratio of the S1-cleaved band to the S2-cleaved 
band is presented. (C) Effect of Yme1L knockdown on the pro-
teolytic processing of isoforms 5, 6, and 8. Samples were 
analyzed as in B. The S1- and S2-cleaved products of isoforms 
6 and 8 are labeled.CONTROL OF OPA1 FUNCTION BY PROTEOLYTIC PROCESSING • SONG ET AL. 755
least three clearly tubular mitochondria. Finally, fragmented refers to cells 
that contain spherical mitochondrial fragments with no more than two short 
tubules found. In the parental OPA1-null cell line, all cells lacked any tubular 
mitochondria and, thus, belonged to the last class.
Online supplemental material
Fig. S1 shows that OPA1-null cells expressing a single OPA1 RNA splice 
form have extensive fusion activity in the PEG cell hybrid assay. Online 
supplemental material is available at http://www.jcb.org/cgi/content/
full/jcb.200704110/DC1.
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